Abstract
ABSTRACTIn situ forming implants (ISIs) based on poly(lactic acid-co-glycolic acid) (PLGA) containing leuprolide acetate/β-cyclodextrin (LA/β-CD) complexes were prepared. Incorporation of LA or complexes did not change Tg values of ISIs (48.4–49.6°C). ISIs containing complexes with more β-CD content showed higher surface and bulk porosity. Higher β-CD portion in complexes improved solvent release, decreased initial burst release and facilitated diffusion out of drug for corresponding ISIs. Complexation of LA with β-CD (1/10, w/w) significantly improved its stability within PLGA matrix before release (total LA release of 91.3%). ISIs did not show any cellular cytotoxic effects against L929 fibroblast cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Polymeric Materials and Polymeric Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
